Advertisement

Outcomes of Patients With an Ultra-Low–Risk 70-Gene Signature in the MINDACT Trial
Posted: 03/07/2022 | By: Melissa E. Fryman, MS

Question 1 of 5

70-gene signature ultra-low–risk breast cancers account for what percentage of all breast cancers?

Choose 1

A
5% to 10%
B
10% to 15%
C
15% to 20%
D
20% to 25%

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage